Liu G, Zhu J, Cai C, Zhou Y, Yu M, Fu Z, Gong Y, Yang B, Li Y, Zhou Q, Lin Q, Ye H, Ye L, Zhao X, Li Z, Chen R, Han F, Tang C, Zeng B (2015) Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients
These effects typically diminish quickly and represent the medication working as intended
Antagonistic activity of soil acidophilic actinomycetes
Guys Hosp
The way your body responds to the medication can be influenced by various factors like your metabolism, lifestyle, and adherence to the treatment plan
The article says ongoing provider contact every 2 to 4 weeks during titration, then monthly afterward, is essential for monitoring tolerability and metabolic response